Learn more about our Advocacy work.
As medtech innovation outpaces coding and payment systems designed for another era, the threat of meritless False Claims Act cases deters important advancement in technologies patients need.
Nadim Yared, President and CEO of medical technology startup CVRx, recently joined AdvaMed®’s Scott Whitaker on the Medtech POV Podcast to discuss his expansive medtech career – from engineer to CEO –…
Today, the Advanced Medical Technology Association® (AdvaMed®) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its proposal to repeal the Medicare Coverage of Innovative Technology (MCIT)…
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity…
The MedTech Conference, the Advanced Medical Technology Association®’s (AdvaMed®) premier annual gathering, wrapped up Thursday following four days of networking opportunities, presentations and panel discussions on the top issues facing…
A new study commissioned by the Advanced Medical Technology Association® (AdvaMed®) found that two-thirds of medical technology companies say semiconductors, firmware, and/or embedded software are required for at least half of the…
From September 27-30, The Medtech Conference 2021 will host a robust line-up of thought leaders from inside and outside the health care arena to discuss the top issues facing the medical technology industry and…
In the most recent episode of the Medtech POV Podcast, a top medtech venture capital investor argued that if a medical device has received FDA approval as safe and effective…
AdvaMed®, the leading global trade association for medical technology manufacturers, released the following statement from President and CEO Scott Whitaker on the Administration’s proposal to fully repeal the Medicare Coverage…
Justin Klein recently joined AdvaMed® CEO Scott Whitaker for an episode of Medtech POV to talk about his expansive career in medtech and some of today’s most pressing issues across…